The Claudia von Schilling Foundation for Breast Cancer Research Germany is a specialized medical research funder focused almost entirely on breast cancer (mammary carcinoma) and related therapeutic advances. It supports scientifically grounded projects ranging from novel treatment approaches and nanotechnology to palliative care, reconstruction using patient-derived tissue, and the dissemination of breast cancer research findings. Its grantees are typically university hospitals, oncology centers, and research institutes in Germany and Switzerland, with some international collaborations such as Harvard Medical School.
Competitive project grants for scientific research and therapeutic development; likely medium-sized research awards, awarded through announced calls or unsolicited proposals rather than a fixed public deadline, with emphasis on academic and clinical research partners in Germany and neighboring countries.
Regístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.
Watch the foundation website for announced calls, since no fixed public deadline is stated. Strong applications should be breast-cancer-specific, scientifically rigorous, and ideally involve academic medical centers or established oncology research groups in Germany, Switzerland, or international collaboration. Emphasize novel therapeutic relevance, translational impact, and clear alignment with the foundation’s breast cancer mission.
Financiamiento actual y próximo de Claudia von Schilling Foundation for Breast Cancer Research Germany al que tu organización sin fines de lucro podría postularse.
¿Quién puede postularse? Recognizes special achievements in breast cancer medicine and relevant basic cancer research. Preferably, but not exclusively, for scientists in the German-speaking region. Awarded at the foundation’s discretion after scientific review.
Fecha límite: Annual call; current PDF announcement available.
¿Quién puede postularse? Intended for young, promising scientists and working groups; applicants should be no older than 40 at the time the submitted work is completed. Awarded using the same standards as the Claudia von Schilling Prize.
Fecha límite: Annual call; current PDF announcement available.
¿Quién puede postularse? Projects must align with the foundation’s statutory purpose and funding profile, promise genuinely new and scientifically sound approaches in breast cancer treatment or related measures, and generally follow relevant research funding guidelines (e.g., DFG-style requirements). Applicants must provide a project title, applicant details, detailed project description, current research status, scope and duration of planned measures, CV/scientific background, and publication record.
Fecha límite: No fixed deadline stated; projects can be presented outside a call for proposals.
¿Quién puede postularse? Projects must align with the foundation's statutory purpose (breast cancer research and palliative medicine) and conform to established funding guidelines (e.g., comparable to DFG requirements). Applications should include project title, applicants, detailed project description, research status, scope, duration, scientific CVs and publication records. For multi-applicant projects, specify legal applicant responsible for fund administration.
Fecha límite: No fixed public deadlines stated. Funding may be allocated via announced calls or via unsolicited proposals submitted at any time.
Haz seguimiento de estas fechas límite, recibe recordatorios y descubre qué tan bien encaja tu organización — gratis con una cuenta de Kindora.
Crea una cuenta gratisLas fechas límite y los requisitos de elegibilidad son un resumen de fuentes públicas y pueden cambiar — confirma siempre los detalles en la página oficial de solicitud del financiador antes de postularte.